Purity Specifications, Storage and Distribution for Medications Development
National Institutes of Health · NATIONAL INSTITUTES OF HEALTH
Capture briefs (a one-page, shareable copy of this page) are part of Pro. The CSV here holds the notice, its timeline and past awards.
Where this opportunity stands
Every notice posted under solicitation 75N98026R00136 in this department, oldest first.
- Jul 30, 2026 · this noticeSpecial Notice
- Jul 30, 2026Special NoticeOpen
Next steps for this stage
Standard steps for the notice type; not advice about this buyer.
- Answer the notice: this is when the requirement can still be shaped.
- Contact the contracting officer named on the notice.
- Check who won similar work; they are the likely bidders.
What the notice says
TITLE: Purity Specifications, Storage and Distribution for Medications Development This is a Sources Sought notice. THIS IS NOT A REQUEST FOR PROPOSALS, ABSTRACTS, OR QUOTATIONS. This notice is for information and planning purposes only and does not commit the Government to any contractual agreement. The Government does not intend to award a contract based on responses under this announcement nor otherwise pay for preparing any information sent for the Government's use. Any proprietary information should be so marked. PROJECT REQUIREMENTS The National Institute on Drug Abuse (NIDA) seeks capab… (show all)
ility statements from small businesses having the in-house capability to act as a centralized repository for compounds (i.e., chemical and biological) from domestic and international investigators, commercial sources, and pharmaceutical companies. Specifically, the project requires the following tasks: The major goal of this project is to provide NIDA and other NIH Institutes with a holding site which has the capability to inventory, analyze and store compounds, prepared under both non-GMP (Good Manufacturing Practices) and GMP conditions, in amounts ranging from milligram quantities to several kilograms. In accordance with the Controlled Substances Act of 1970, DEA Research Registration for Schedules II to V and potentially Schedule I controlled substances will be required. Please see the attachment for more details.
Who won similar work
27 award notices on SAM.gov in the last 24 months. Matched by: Same agency (National Institutes of Health), same product/service code (PSC) AN11.
Single-winner award sizes (17): middle half $2.7M to $20.0M, median $17.1M; range $552K to $34.9M.
| Winner | Awards | Value | Last |
|---|---|---|---|
| UNIVERSITY OF MARYLAND, BALTIMORE Baltimore MD 21201 USA | 2 | $30.8M | Aug 6, 2026 |
| The TRUSTEES OF COLUMBIA UNIVERSITY IN THE CITY OF NEW YORK 630 WEST 168TH STREET BOX 49 NEW YORK NY 10032 USA | 2 | $17.1M + 1 shared | Sep 25, 2026 |
| MRIGLOBAL Kansas City MO 64110 USA | 2 | $5.0M + 1 shared | Jul 17, 2026 |
| THE MCLEAN HOSPITAL CORPORATION | 1 | $34.9M | Nov 21, 2025 |
| UNIVERSITY OF MIAMI Coral Gables FL 33146 USA | 1 | $26.6M | Nov 21, 2025 |
| WESTAT, INC. | 1 | $21.4M | Sep 25, 2026 |
| RESEARCH TRIANGLE INSTITUTE Durham NC 27709 USA | 1 | $20.0M | Mar 17, 2025 |
| UNIVERSITY OF PITTSBURGH - OF THE COMMONWEALTH SYSTEM OF HIGHER EDUCATION Pittsburgh PA 15260 USA | 1 | $19.9M | Nov 21, 2025 |
| ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI New York NY 10029 USA | 1 | $18.5M | Nov 21, 2025 |
| Greater Los Angeles Veterans Research and Education Foundation Los Angeles CA 90073 USA | 1 | $17.7M | Nov 21, 2025 |
Value counts single-winner awards. "Shared" awards are multiple-award contracts that list every winner with the same total ceiling; that ceiling is not one company's win, so it is not added in. Revenue next to a ticker is the company's last annual revenue from its 10-K.
- Sep 28, 2026Versiti Blood Health, Inc.$7.4M (shared ceiling)A--Recipient Epidemiology and Donor Evaluation Study
- Sep 28, 2026EMORY UNIVERSITY 1599 CLIFTON ROAD NE 4TH FLOOR MAILSTOP 1599-001-1BA Atlanta GA 30322 USA$7.4M (shared ceiling)A--Recipient Epidemiology and Donor Evaluation Study
- Sep 25, 2026The TRUSTEES OF COLUMBIA UNIVERSITY IN THE CITY OF NEW YORK 630 WEST 168TH STREET BOX 49 NEW YORK NY 10032 USA$17.1MA--Recipient Epidemiology and Donor Evaluation Study
- Sep 25, 2026The TRUSTEES OF COLUMBIA UNIVERSITY IN THE CITY OF NEW YORK 630 WEST 168TH STREET BOX 49 NEW YORK NY 10032 USA$7.4M (shared ceiling)A--Recipient Epidemiology and Donor Evaluation Study
- Sep 25, 2026WESTAT, INC.$21.4MA--REDS-V-Data Coordinating Center
- Sep 25, 2026VITALANT 9305 E VIA DE VENTURA Scottsdale AZ 85258 USA$7.4M (shared ceiling)A--The Recipient Epidemiology and Donor Evaluation St
- Aug 6, 2026UNIVERSITY OF MARYLAND, BALTIMORE Baltimore MD 21201 USA$552KRNCP PORTFOLIO-WIDE DOSIMETRY VERIFICATION SERVICES
- Jul 17, 2026MRIGLOBAL Kansas City MO 64110 USA$5.0MAnalytical Services Center for Medications Development Program
- May 5, 2026MRIGLOBAL Kansas City MO 64110 USA$50.0M (shared ceiling)A--Drug Manufacturing and Formulation Program (DMFP)
- May 5, 2026CURIA GLOBAL INC$50.0M (shared ceiling)A--Drug Manufacturing and Formulation Program (DMFP)
Competitive landscape
For the 8 most frequent past winners above. Lobbying is matched by the company's exact name or exact ticker; agencies are as named on the filings.
- 0 of these past winners lobbied Natl Institutes of Health (NIH) since 2024 (0 filings)
- 0 of their lobbyists list a past Natl Institutes of Health (NIH) job
- No corporate PAC money from them to the overseeing committees since 2024
- 0 foreign-agent (FARA) registrations
Policy around it
Bills the past winners named while lobbying this agency's issues, rules from the department, and executive orders that name the agency, last 12 months.
- 0 bills named on the past winners' lobbying filings
- 0 rules from the department in the last 12 months
- 0 executive orders naming the agency in the last 12 months
Market
For past winners matched exactly to a listed company. Insider trades are open-market buys and sells (Form 4) in the last 90 days, shown as facts; our own study found insiders do not reliably buy ahead of awards. A sale marked 10b5-1 was made under a trading plan set up in advance.
- 0 of the past winners are listed companies
- 0 insider buys and 0 insider sells at them in the last 90 days
Sources: SAM.gov notices and award notices; Senate LDA lobbying filings; FEC filings; FARA; Federal Register; congress.gov; SEC Form 4. Every row above links to its record.
Companies are matched to tickers by exact name only. A company we could not match shows no market rows; that is a miss, not a finding.